Search Close Search
Page Menu

David M. Harlan, MD

Co-Director, Diabetes Center of Excellence,

The William and Doris Krupp Professor of Medicine,

Research Director, Breakthrough T1D (formerly JDRF) Northeast Research Collaboration

Dr. Harlan is an internationally acclaimed diabetes physician-scientist at UMass Chan Medical School and UMass Memorial Medical Center in Worcester, Massachusetts

Diabetes Care

While chief of the Diabetes Division at UMass Memorial, Dr. Harlan increased volume and significantly improved the level of care in the adult diabetes clinic. He leads by example and strives to improve care delivery systems. Dr. Harlan's patients benefit from his extensive knowledge of the disease and how he listens to each individual and works with them to develop a diabetes management plan. He believes that the person living with diabetes is the most critical member of their care team.

Type 1 Diabetes Research

Over the past 40 years, Dr. Harlan has led basic and clinical research exploring the pathophysiology of diabetes. His clinical trials are testing new therapies and investigating human biology related to diabetes and its treatment. His current research is focused on beta cell biology and the anti-beta cell immune response underlying type 1 diabetes. 

In the News

JDRF Appoints David Harlan, MD, as Director of their New England Research Collaboration

Dr. Harlan's professional passion became personal with his son's diagnosis of Type 1 diabetes, as mentioned in this Spectrum News coverage of the JDRF (now Breakthrough T1D) appointing him as Director of the regional research collaboration. In this video, he explains how the scientists are executing their plan to cure Type 1 diabetes.

Additional News Coverage 

2022 Rachmiel Levine Award at the City of Hope Levine-Riggs Diabetes Research Symposium

 Harlan Rachmiel Levine Award Lecture.png
Dr. Harlan was recognizing for his diabetes research career.  In this video he shares his award lecture with colleagues at Worcester's UMass Memorial Medical Center

HLA Class II antigen processing and presentation pathway components demonstrated by transcriptome and protein analyses of beta cells from donors with type 1 diabetes

We definitively show that beta cells express these important immune pathway gene products, resolving a three decades long debate